SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-014419
Filing Date
2023-04-25
Accepted
2023-04-25 16:06:04
Documents
21

Document Format Files

Seq Description Document Type Size
1 DEF 14A mcrb-20230425.htm   iXBRL DEF 14A 2100071
2 GRAPHIC img114728045_0.jpg GRAPHIC 117747
3 GRAPHIC img114728045_1.jpg GRAPHIC 65052
4 GRAPHIC img114728045_2.jpg GRAPHIC 129593
5 GRAPHIC img114728045_3.jpg GRAPHIC 113814
6 GRAPHIC img114728045_4.jpg GRAPHIC 65052
7 GRAPHIC img114728045_5.jpg GRAPHIC 516751
8 GRAPHIC img114728045_6.jpg GRAPHIC 495560
  Complete submission text file 0000950170-23-014419.txt   6913258

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mcrb-20230425_def.xml EX-101.DEF 8084
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mcrb-20230425.xsd EX-101.SCH 6669
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mcrb-20230425_lab.xml EX-101.LAB 16552
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mcrb-20230425_pre.xml EX-101.PRE 9792
15 EXTRACTED XBRL INSTANCE DOCUMENT mcrb-20230425_htm.xml XML 383677
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37465 | Film No.: 23844880
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences